Literature DB >> 31759060

Intravenous Bevacizumab Reduces Transfusion Requirements and Endoscopic Interventions in Patients With Gastric Antral Vascular Ectasia and Small Bowel Angioectasia.

Hasan Ahmad Hasan Albitar1, Yahya Almodallal2, Konstantinos A Papadakis3, Elizabeth Rajan3, Patrick S Kamath3, Vivek N Iyer4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31759060     DOI： 10.1053/j.gastro.2019.11.027

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

1.  The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report.

Authors:  Ryan Patrick Fanning; Sara Strout; Nicholas R Rowan; Clifford R Weiss; Panagis Galiatsatos
Journal:  J Med Cases       Date:  2022-06-02

2. 

Authors:  Gian Eugenio Tontini; Lorenzo Dioscoridi; Alessandro Rimondi; Paolo Cantù; Flaminia Cavallaro; Aurora Giannetti; Luca Elli; Luca Pastorelli; Francesco Pugliese; Massimiliano Mutignani; Maurizio Vecchi
Journal:  Endosc Int Open       Date:  2022-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.